Academic Background The continuous mutation of SARS-CoV-2 has posed ongoing challenges to the efficacy of vaccines and antibody therapies. Traditional evaluation methods can only test against existing variants and fail to predict future immune escape mutations. To address this, Noor Youssef and colleagues developed the EVE-Vax (Evolutionary Variant...